[HTML][HTML] Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy
M Frick, J Fischer, A Helbling, F Ruëff… - Journal of allergy and …, 2016 - Elsevier
Background Component resolution recently identified distinct sensitization profiles in honey
bee venom (HBV) allergy, some of which were dominated by specific IgE to Api m 3 and/or …
bee venom (HBV) allergy, some of which were dominated by specific IgE to Api m 3 and/or …
Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy
M Frick, J Fischer, A Helbling… - Journal of Allergy …, 2016 - portal.findresearcher.sdu.dk
BACKGROUND: Component resolution recently identified distinct sensitization profiles in
honey bee venom (HBV) allergy, some of which were dominated by specific IgE to Api m 3 …
honey bee venom (HBV) allergy, some of which were dominated by specific IgE to Api m 3 …
Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy.
M Frick, J Fischer, A Helbling, F Ruëff, D Wieczorek… - 2016 - mediatum.ub.tum.de
Component resolution recently identified distinct sensitization profiles in honey bee venom
(HBV) allergy, some of which were dominated by specific IgE to Api m 3 and/or Api m 10 …
(HBV) allergy, some of which were dominated by specific IgE to Api m 3 and/or Api m 10 …
Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy.
M Frick, J Fischer, A Helbling, F Ruëff, D Wieczorek… - 2016 - cabidigitallibrary.org
Background: Component resolution recently identified distinct sensitization profiles in honey
bee venom (HBV) allergy, some of which were dominated by specific IgE to Api m 3 and/or …
bee venom (HBV) allergy, some of which were dominated by specific IgE to Api m 3 and/or …
Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy.
M Frick, J Fischer, A Helbling, F Ruëff… - The Journal of allergy …, 2016 - sonar.ch
OBJECTIVE We performed a retrospective analysis of component-resolved sensitization
profiles in HBV-allergic patients and association with treatment outcome. METHODS HBV …
profiles in HBV-allergic patients and association with treatment outcome. METHODS HBV …
[PDF][PDF] Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy
M Frick, J Fischer, A Helbling, F Ruëff, D Wieczorek… - scholar.archive.org
Background: Component resolution recently identified distinct sensitization profiles in honey
bee venom (HBV) allergy, some of which were dominated by specific IgE to Api m 3 and/or …
bee venom (HBV) allergy, some of which were dominated by specific IgE to Api m 3 and/or …
Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy
M Frick, J Fischer, A Helbling… - The Journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Component resolution recently identified distinct sensitization profiles in honey
bee venom (HBV) allergy, some of which were dominated by specific IgE to Api m 3 and/or …
bee venom (HBV) allergy, some of which were dominated by specific IgE to Api m 3 and/or …
[引用][C] Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy
M Frick, J Fischer, A Helbling, F Rueff… - Journal of Allergy …, 2016 - ub01.uni-tuebingen.de
Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom
immunotherapy Predominant Api m 10 sensitization as risk factor for treatment failure in honey …
immunotherapy Predominant Api m 10 sensitization as risk factor for treatment failure in honey …
Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy
M Frick, J Fischer, A Helbling, F Ruëff… - Journal of allergy and …, 2016 - boris.unibe.ch
BACKGROUND Component resolution recently identified distinct sensitization profiles in
honey bee venom (HBV) allergy, some of which were dominated by specific IgE to Api m 3 …
honey bee venom (HBV) allergy, some of which were dominated by specific IgE to Api m 3 …
Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy.
M Frick, J Fischer, A Helbling, F Ruëff… - The Journal of allergy …, 2016 - folia.unifr.ch
OBJECTIVE We performed a retrospective analysis of component-resolved sensitization
profiles in HBV-allergic patients and association with treatment outcome. METHODS HBV …
profiles in HBV-allergic patients and association with treatment outcome. METHODS HBV …